SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is surging after announcing preliminary Q3 revenue that significantly exceeded prior guidance and analyst consensus, indicating robust demand for its AI infrastructure solutions. The community is highly bullish, anticipating sustained growth as the company plays a crucial role in the ongoing data center buildout.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending following the FDA's issuance of a Complete Response Letter for its Hunter syndrome gene therapy, RGX-121, citing concerns with trial design and the appropriateness of its surrogate endpoint. The community is actively debating the broader implications for gene therapies, RGNX's financial outlook, and potential impacts on its Duchenne and AbbVie-partnered programs.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending following a drastic stock plunge driven by the abrupt departure of its CFO and general counsel, an SEC investigation into cash management, and an accounting review exposing internal control weaknesses and revised future guidance, sparking intense community debate between those foreseeing catastrophe and others viewing it as an extreme overreaction and buying opportunity.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

MSLE is actively discussed following its recent NASDAQ listing, a reverse split, and a substantial equity raise. While optimists view the financing as a strong vote of confidence in its "revolutionary" muscle regeneration drug for Duchenne patients and foresee potential acquisition, skeptics caution about dilution and characterize early clinical data as premature hype.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is seeing significant trending activity with its community actively working to "drop a zero" from its price, driven by excitement over its AI-powered utility, new exchange listings, and ecosystem expansion on the Base chain. Community members are enthusiastically accumulating, citing its undervalued market cap and growing revenue, even amid broader crypto market volatility.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

The community is actively discussing Rocket Companies following its CEO's optimistic remarks about achieving multi-year highs in mortgage loan volume and gain-on-sale performance, leading to expectations of a significant re-rating as its integrated platform benefits from housing market normalization and industry consolidation.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending after announcing strong preliminary revenue results and expanding AI-driven healthcare partnerships, which are seen as catalysts for its growth. The community is actively discussing its significant short interest and recent institutional buying, sparking debate on a potential short squeeze.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health (OSCR) is trending sharply higher after the House passed a bill to extend ACA subsidies, fueling investor optimism for significant upside and a potential short squeeze, though community debate persists on the bill's Senate fate and the company's path to profitability ahead of its upcoming earnings.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify (SPOT) is seeing heated debate leading into its Q4 earnings report, as bullish analysts and the rollout of new AI-powered features and price hikes contend with investor concerns over its valuation and a recent music catalog leak.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing extreme volatility following a patent infringement lawsuit from Novo Nordisk and FDA scrutiny regarding its compounded semaglutide weight-loss pill, which the company has now ceased offering. The community is fiercely debating whether this represents a fundamental threat and further downside, or an overreaction presenting a significant short squeeze opportunity for a company with strong core business segments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)?

Discover Financial Services lowered to Hold at Jefferies

Investing.com -- Jefferies downgraded Discover Financial Services (NYSE:DFS) to Hold from Buy, citing the imminent close of its acquisition by  Capital One  (NYSE:COF) on May 18. 

Netflix, Barrick Gold rise premarket; Tesla slips

Investing.com - U.S. stock futures slipped on Monday as investors assessed the impact of President Donald Trump's tariff plans and gauged his scathing remarks about Federal Reserve Chair Jerome Powell.

Capital One stock surges after Discover Financial deal approved

Investing.com -- Capital One shares are up premarket Monday after U.S. regulators approved the bank’s $35 billion acquisition of Discover Financial.

Earnings Preview: What To Expect From Discover Financial Services' Report

Discover Financial Services is scheduled to announce its first-quarter results later this month, with analysts anticipating a significant earnings growth.

Capital One (COF) and Discover Financial Services (DFS) drew retail chatter on Thursday after the Department of Justice reportedly told financial regulators in a confidential memo that it didn’t have sufficient evidence to block the $35 billion merger between the credit card firms.According to a Bloomberg report citing people familiar with the matter, the DOJ memo to the Federal Reserve and Office of the Comptroller of the Currency would allow the financial regulators to approve the deal.The report added that the memo indicates a change of direction after DOJ antitrust officials had outlined some concerns that the deal could harm competition in an earlier version of the document during the Biden administration.The earlier memo included concerns about the potential loss of head-to-head competition for first-time credit card holders and the potential for Capital One to use Discover to evade regulatory caps on interchange fees for its debit card business, Bloomberg reported.The two companies' shareholders had voted in favor of the deal in February.On Thursday, Capital One and Discover Financial shares slumped 10% and 8.3%, respectively, amid a broader market selloff triggered by President Donald Trump’s tariffs.Retail sentiment about Capital One on Stocktwits moved higher into the ‘bullish’ (74/100) territory than a day ago, while retail chatter jumped to ‘extremely high.’<figure class="image"><img style="aspect-ratio:882/187;" src="https://news.stocktwits-cdn.com/COF_April_4_JPG_7c6d52654c.webp" alt="COF’s Sentiment Meter and Message Volume as of 04:06 a.m. ET on April 4, 2025 | Source: Stocktwits" width="882" height="187"><figcaption>COF’s Sentiment Meter and Message Volume as of 04:06 a.m. ET on April 4, 2025 | Source: Stocktwits</figcaption></figure>Retail sentiment about Discover Financial remained in the ‘extremely bullish’ (75/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:874/196;" src="https://news.stocktwits-cdn.com/DFS_April_4_JPG_0521bae48a.webp" alt="DFS’s Sentiment Meter and Message Volume as of 04:07 a.m. ET on April 4, 2025 | Source: Stocktwits" width="874" height="196"><figcaption>DFS’s Sentiment Meter and Message Volume as of 04:07 a.m. ET on April 4, 2025 | Source: Stocktwits</figcaption></figure>One retail trader said Capital One stock would have been in the $190 to $200 range had Trump not unveiled tariffs.<stembedurl>https://stocktwits.com/AlarmedSheiky/message/610331846</stembedurl><a href="https://stocktwits.com/symbol/COF">Capital One shares</a> have fallen 8.9% year-to-date, while <a href="https://stocktwits.com/symbol/DFS">Discover shares</a> are down 7.8%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/oil-stocks-slump-after-trump-tariffs-opec-production-raise/chf9CZrRbeD">One-Two Punch For Oil Stocks: OPEC+ Output Hike Piles On Trump Tariff Fallout, Retail Sentiment Sours</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mergers and Acquisitions message in neon lights. (Image Courtesy: Getty Images)

Capital One, Discover Financial In Focus After DOJ Reportedly Greenlights $35B Merger, Retail’s Bullish

According to a Bloomberg report, the DOJ decision would allow the Federal Reserve and the Office of the Comptroller of the Currency to approve the deal.

Capital One, Discover Financial In Focus After DOJ Reportedly Greenlights Merger

Equity

Stock Index Futures Gain Ahead of U.S. Tariffs Announcement, JOLTs Report and PMI Data on Tap

June S&P 500 E-Mini futures (ESM25) are up +0.12%, and June Nasdaq 100 E-Mini futures (NQM25) are up +0.24% this morning as investors await the latest reading on U.S. job openings and manufacturing sector surveys.

Capital One Financial (COF) and Discover Financial (DFS) stocks saw a jump in retail chatter on Monday after <a target="_blank" rel="noopener noreferrer nofollow" href="https://thecapitolforum.com/capital-one-discover-financial-doj-refocuses-on-how-deal-would-affect-borrowers/">a report</a> by the publication Capitol Forum said that the Department of Justice is divided over the strength of a potential antitrust case against the two companies' $35 billion merger.Earlier this month, the shares of the <a href="https://stocktwits.com/news-articles/markets/equity/discover-financial-capital-one-stocks-slip-over-reports-of-doj-s-concerns-on-pending-merger/ch7K5JzRbcL">credit card firms fell</a> after the Capital Forum reported that Justice Department staff believe the deal would be anti-competitive in the subprime sector.The recent report, published on March 28, also said that the DOJ is currently refocusing on how the deal might affect borrowers without credit histories.Capital One and Discover shareholders voted in favor of the deal in February. However, the merger has yet to receive approval from the Federal Reserve and the Office of the Comptroller of the Currency.In October, New York Attorney General Letitia James had urged a state court to issue subpoenas to Capital One related to an antitrust case on the merger. The two companies have a combined $16 billion in credit card loans in New York.<a href="https://stocktwits.com/symbol/COF">Capital One shares</a> rose 3.3%, while <a href="https://stocktwits.com/symbol/DFS">Discover shares</a> rose 7.5% on Monday.According to The Fly, Barclays analysts said last week that reports about the DOJ's competitive concerns in the subprime card market shouldn't derail deal.The brokerage also noted that there could be a path to regulatory approval through divestiture, which would, according to its estimates, result in only a modest reduction in earnings estimates.Retail sentiment about Capital One on Stocktwits jumped to ‘bullish’ (56/100) territory from ‘bearish’(40/100) a day ago, while retail chatter rose to ‘normal.’<figure class="image"><img style="aspect-ratio:805/176;" src="https://news.stocktwits-cdn.com/COF_April_1_JPG_3aa01d6fa3.webp" alt="COF’s Sentiment Meter and Message Volume as of 01:25 a.m. ET on April 1, 2025 | Source: Stocktwits" width="805" height="176"><figcaption>COF’s Sentiment Meter and Message Volume as of 01:25 a.m. ET on April 1, 2025 | Source: Stocktwits</figcaption></figure>While retail sentiment about Discover stayed in the ‘bullish’ (59/100) territory and retail chatter rose to ‘high.’<figure class="image"><img style="aspect-ratio:801/180;" src="https://news.stocktwits-cdn.com/DFS_April_1_JPG_c20b49b712.webp" alt="DFS’s Sentiment Meter and Message Volume as of 01:26 a.m. ET on April 1, 2025 | Source: Stocktwits" width="801" height="180"><figcaption>DFS’s Sentiment Meter and Message Volume as of 01:26 a.m. ET on April 1, 2025 | Source: Stocktwits</figcaption></figure>One retail trader cited the chatter around the deal as the reason behind the stocks’ upward movement and said that Capital One stock could rise to $190 rapidly.<stembedurl>https://stocktwits.com/Jamtrades/message/609818676</stembedurl>Capital One shares have fallen marginally year-to-date, while Discover is down 2.4%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/open-lending-stock-falls-on-bigger-q4-loss/chf2eu0Rb4q">Open Lending Stock Falls On Bigger Q4 Loss, Retail Sits On The Fence</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Discover logo displayed on a phone screen and a laptop keyboard are seen in this illustration photo taken in Krakow, Poland on December 1, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Capital One, Discover Financial In Spotlight After Report Hints At Removal Of DOJ Hurdle To $35B Deal, Retail’s Bullish 

The recent report, published on March 28, said the Justice Department is refocusing on how the deal might affect borrowers without credit histories.

Capital One, Discover Financial Draw Bullish Chatter On Reports Of Removal Of DOJ Hurdle

Discover provides banking and credit products that help people achieve their goals—from establishing good credit to paying for a college education to consolidating debt. In payments, their networks connect banks, cardmembers, and merchants with innovative commerce solutions.

Discover Financial Services

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

DFS
Discover Financial Services

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DFS News

DFSDiscover Financial Services